OLMA logo

OLMA
Olema Pharmaceuticals Inc

1,792
Mkt Cap
$1.19B
Volume
1.07M
52W High
$36.26
52W Low
$3.89
PE Ratio
-6.75
OLMA Fundamentals
Price
$13.68
Prev Close
$14.06
Open
$13.89
50D MA
$14.89
Beta
1.04
Avg. Volume
846,475.26
EPS (Annual)
-$1.87
P/B
2.49
Rev/Employee
$0.00
$1,673.91
Loading...
Loading...
News
all
press releases
Olema Oncology Sees Early Hope As Cancer Drug Shows Tumor Shrinkage In Phase 1 Study
Early ASCO data for OP-3136 pointed to encouraging anti-cancer activity with a clean safety profile, adding momentum to OLMA’s pipeline story.
News Placeholder
More News
News Placeholder
Olema Pharmaceuticals (OLMA) Expected to Announce Quarterly Earnings on Tuesday
Olema Pharmaceuticals (NASDAQ:OLMA) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-olema-pharmaceuticals-inc-stock...
News Placeholder
Jennison Associates LLC Takes Position in Olema Pharmaceuticals, Inc. $OLMA
Jennison Associates LLC purchased a new stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 963,997 shares of the company's stock, valued at approximatel...
News Placeholder
Pictet Asset Management Holding SA Trims Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA
Pictet Asset Management Holding SA lessened its holdings in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 69.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 502,568...
News Placeholder
Wall Street Zen Upgrades Olema Pharmaceuticals (NASDAQ:OLMA) to "Sell"
Wall Street Zen raised Olema Pharmaceuticals from a "strong sell" rating to a "sell" rating in a research report on Monday...
News Placeholder
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the fourteen brokerages that are covering the company, Marketbeat...
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Downgraded to "Strong Sell" Rating by Wall Street Zen
Wall Street Zen downgraded shares of Olema Pharmaceuticals from a "sell" rating to a "strong sell" rating in a research note on Sunday...
News Placeholder
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totaling...
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Raised to "Sell" at Wall Street Zen
Wall Street Zen upgraded shares of Olema Pharmaceuticals from a "strong sell" rating to a "sell" rating in a research note on Saturday...
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% Higher - Here's What Happened
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 7.7% - What's Next...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available